ABSTRACT

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused Coronavirus pandemic (COVID-19). Repurposing of antimalarial drugs as a potential treatment option for hospitalized, non-hospitalized as well for prevention against SARS CoV-2 have been researched as potential COVID‑19 treatments, with some moving into clinical trials. This review article revisits the evidence and draws comparison regarding their safety and efficacy.

Key Words: Antimalarial Drugs, COVID-19, Chloroquine and Hydroxychloroquine, SARS CoV-2.

How to cite this: Zahid M, Waqar K, Tahir N.  Recapitulation of Antimalarial Drugs use in the Prevention and Treatment of Novel Coronavirus Disease. Life and Science. 2020; 1(suppl): 45-52 .  doi: http://doi.org/10.37185/LnS.1.1.149